Extract Stroke remains the second leading cause of death and the primary cause of adult disability in the European Union, despite advances in acute care and secondary prevention [1]. Obstructive sleep apnoea (OSA) is a significant independent risk factor for stroke [2], affecting nearly one billion people globally [3]. Post-stroke, OSA is highly prevalent, with up to two-thirds of stroke patients experiencing some degree of OSA and 40% exhibiting an apnoea - hypopnoea index (AHI) above 20 events·h - 1 even months after the event [4].
Extract Stroke remains the second leading cause of death and the primary cause of adult disability in the European Union, despite advances in acute care and secondary prevention [1]. Obstructive sleep apnoea (OSA) is a significant independent risk factor for stroke [2], affecting nearly one billion people globally [3]. Post-stroke, OSA is highly prevalent, with up to two-thirds of stroke patients experiencing some degree of OSA and 40% exhibiting an apnoea - hypopnoea index (AHI) above 20 events·h - 1 even months after the event [4].